tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INMB Stock Latest News

INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
Company AnnouncementsINmune Bio Advances CORDStrom Toward Rare Disease Commercialization
4d ago
8K
INMB
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
PremiumRatings
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
5d ago
INMB
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
PremiumThe Fly
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
6d ago
INMB
INmune Bio submits pre-submission package for CORDStrom with MHRA
PremiumThe Fly
INmune Bio submits pre-submission package for CORDStrom with MHRA
8d ago
INMB
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating
PremiumRatings
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating
21d ago
INMB
INmune Bio outlines 2026 regulatory path in shareholder letter
PremiumCompany AnnouncementsINmune Bio outlines 2026 regulatory path in shareholder letter
21d ago
8K
INMB
INmune Bio CEO says ‘well positioned for continued execution’
Premium
The Fly
INmune Bio CEO says ‘well positioned for continued execution’
22d ago
INMB
Inmune Bio Amends April 2024 Investor Warrants
Premium
Company Announcements
Inmune Bio Amends April 2024 Investor Warrants
2M ago
8K
INMB
INmune Bio Establishes $65 Million At-The-Market Offering
PremiumCompany Announcements
INmune Bio Establishes $65 Million At-The-Market Offering
2M ago
8K
INMB
Inmune Bio Ends Sales Agreement with RBC and BTIG
PremiumCompany Announcements
Inmune Bio Ends Sales Agreement with RBC and BTIG
2M ago
8K
INMB
Inmune Bio Unveils Promising Alzheimer’s Trial Data
PremiumCompany Announcements
Inmune Bio Unveils Promising Alzheimer’s Trial Data
2M ago
8K
INMB
INmune Bio publishes study on INmune’s CORDStrom platform
PremiumThe Fly
INmune Bio publishes study on INmune’s CORDStrom platform
2M ago
INMB
Inmune Bio Updates Executive Employment Agreements
PremiumCompany AnnouncementsInmune Bio Updates Executive Employment Agreements
3M ago
8K
INMB
INmune Bio announces neuroimaging data from Phase 2 MINDFuL trial
Premium
The Fly
INmune Bio announces neuroimaging data from Phase 2 MINDFuL trial
3M ago
INMB
Inmune Bio Announces New Executive Employment Agreements
Premium
Company Announcements
Inmune Bio Announces New Executive Employment Agreements
3M ago
8K
INMB
INmune Bio Approves Option Repricing Proposal
PremiumCompany Announcements
INmune Bio Approves Option Repricing Proposal
3M ago
8K
INMB
Inmune Bio Advances Immunotherapy Pipeline with Phase 2 Completion
PremiumCompany Announcements
Inmune Bio Advances Immunotherapy Pipeline with Phase 2 Completion
3M ago
8K
INMB
Inmune Bio’s Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Inmune Bio’s Earnings Call Highlights Progress and Challenges
4M ago
INMB
Inmune Bio Reports Q3 2025 Financial Results
PremiumCompany Announcements
Inmune Bio Reports Q3 2025 Financial Results
4M ago
INMB
INmune Bio reports Q3 EPS (24c), consensus (32c)
PremiumThe FlyINmune Bio reports Q3 EPS (24c), consensus (32c)
4M ago
INMB
Inmune Bio to Host Q3 Results Conference Call
Premium
Company Announcements
Inmune Bio to Host Q3 Results Conference Call
4M ago
8K
INMB
INmune Bio CEO to Speak at Maxim Growth Summit
Premium
Company Announcements
INmune Bio CEO to Speak at Maxim Growth Summit
4M ago
8K
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >